NewsRx

Search our medical news database

Hemorrhagic Stroke

Study Using Endovascular Cooling Catheter For Fever Control Is Initiated

Published in Medical Devices and Surgical Technology Week, September 9th, 2001

INNERCOOL Therapies, Inc. announced it is initiating a clinical study to investigate the use of its Celsius ControlTM System in patients who develop a fever after suffering a ruptured brain aneurysm (hemorrhagic stroke).

The Celsius Control System is a state-of-the-art endovascular catheter technology that exchanges heat directly with blood flowing in the vessels of the body to induce and/or reverse hypothermia. Hypothermia has the potential to prevent tissue or organ damage during periods of ischemia that occur during stroke and heart attack or for temperature control in surgical and critical care applications.

The study will be...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook